BioSpace News Archive

Ben-Gurion University of the Negev (BGU) and Soroka Medical Center announced a strategic collaboration for the development of novel technologies in the filed of Bio-Convergence (a field that combines biology with computational technologies and engineering).

Ortho Regenerative Technologies Inc. announced today that the United States Patent and Trademark Office (the “USPTO”) has issued a patent related to the Company’s ORTHO-R soft tissue repair platform.

REGENXBIO Inc. announced it will participate in the following upcoming investor conferences.

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2022 financial results and provided business updates.

Diffusion Pharmaceuticals Inc. today announced that it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the Nasdaq minimum bid price.

Genenta Science announces that its ongoing trial of Temferon™ in glioblastoma multiforme patients who have an unmethylated MGMT gene promoter (uMGMT-GBM) has escalated to the next planned dose.

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to HM43239, an oral, myeloid kinome inhibitor, for the treatment of patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with FLT3 mutation.

EyePoint Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2022 and highlighted recent corporate developments.

ElevateBio, LLC today announced a poster presentation on ElevateBio BaseCamp’s lentiviral vector production platform at the upcoming American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting taking place May 16-19, 2022 in Washington, DC.

Pressure BioSciences, Inc. today announced it has signed a multi-year development and manufacturing agreement with Safer Medical of Montana (“SMM”).